Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

NeoPredics Announces Market Launch of PreFree Across CE-Markets

- Clinical challenge: uncertainty in discharge and admission decisions for women at risk of preeclampsia

- PreFree: the first CE-marked, multimodal prediction model for preeclampsia (biomarkers + clinical data)

- Market launch in CE countries starting Q4 2025

FORT LAUDERDALE, FL / ACCESS Newswire / October 8, 2025 / Preeclampsia remains one of the most serious complications in pregnancy, yet decisions around discharge and admission in suspected cases are often uncertain. Traditional assessment tools lack predictive accuracy, leading to unnecessary hospital stays or delayed recognition of life-threatening risks for pregnant women and their babies.

Thorsten Waloschek, CEO NeoPredics

Beginning in the fourth quarter of 2025, NeoPredics will launch PreFree across CE-markets. PreFree is the first CE-marked multimodal prediction model for preeclampsia, combining biomarkers (sFlt-1/PlGF) with clinical data to enable reliable risk stratification early in pregnancy. It also offers the option of remote patient monitoring directly from home.

"With PreFree, we are laying a new foundation for clinical decision-making in obstetrics. Our mission is to provide physicians with a trusted tool that reduces uncertainty in managing preeclampsia and enhances safety for both pregnant women and their children," said Thorsten Waloschek, CEO of NeoPredics.

The PreFree Solution

PreFree supports clinical decision making with easy-to-interpret personalized risk scores and forecasts. This allows for more targeted interventions, fewer unnecessary hospitalizations, and improved patient outcomes.

Key Benefits:

- Early detection of preeclampsia risk
- Multimodal integration of biomarkers and clinical data
- Two-week risk forecast for timely intervention
- Clear, transparent risk scores to support clinical decision-making
- Remote monitoring for added safety and flexibility

Benefits for Stakeholders

- Clinicians: earlier detection of preeclampsia, clearer admission/discharge decisions, personalized patient management.
- Hospitals: streamlined workflows, shorter lengths of stay, reduced readmissions and costs.
- Pregnant women: greater safety, fewer unnecessary hospitalizations, convenient home-based monitoring.
- Payers: optimized resource allocation, lower overall healthcare costs, improved maternal and neonatal outcomes.

Availability

PreFree will be available across Europe beginning Q4 2025.

About NeoPredics

NeoPredics is an innovative MedTech company headquartered in Switzerland with operational offices in Europe and the United States. The company creates advanced predictive and digital solutions to support clinical decision-making across the maternal, neonatal, and perinatal spectrum. By transforming complex clinical and biomarker data into clear, actionable insights, NeoPredics empowers healthcare providers to anticipate risks, intervene earlier, and improve outcomes for pregnant women, babies, and families worldwide.

Contact Information

Lia Butler
Director of Sales & Marketing, US
lia.butler@neopredics.com
6092736911

.

SOURCE: NeoPredics



View the original press release on ACCESS Newswire

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
+0.00 (0.00%)
AAPL  252.29
+0.00 (0.00%)
AMD  233.08
+0.00 (0.00%)
BAC  51.28
+0.00 (0.00%)
GOOG  253.79
+0.00 (0.00%)
META  716.91
+0.00 (0.00%)
MSFT  513.58
+0.00 (0.00%)
NVDA  183.16
-0.06 (-0.03%)
ORCL  291.31
+0.00 (0.00%)
TSLA  439.31
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.